People · Operator
Named in public records as an officer, director or promoter · active 2014–2021 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Trice Medical, Inc. | — | Healthtech | Series C | $124.2M | $115.8M | 2014 |
| Mobilion Systems, Inc. | — | Biotechnology | Series C | $105.1M | $1.7B | 2021 |
Craig Carra at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Craig Carra on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Garheng Kong | 1 | 16 |
| Jason Smith | 1 | 14 |
| Gary Kurtzman | 1 | 8 |
| Jeffrey O'Donnell | 1 | 7 |
| Heiner Dreismann | 1 | 6 |
| Mark Foster | 1 | 6 |
| Randy Scott | 1 | 5 |
| Jeffrey F. O'Donnell, Sr. | 1 | 5 |
| Todd Sone | 1 | 4 |
| William A Hawkins | 1 | 4 |
| Richard Kienzle | 1 | 3 |
| Michael Steen | 1 | 3 |
| Jeffrey F. O'Donnell | 1 | 3 |
| Richard Washburn | 1 | 2 |
| Michael Albin | 1 | 2 |
| William Rhoda | 1 | 2 |
| Craig K. Carra | 1 | 2 |
| NIMESH SHAH | 1 | 2 |
| Alan Davis | 1 | 2 |
| ERIC C. SALZMAN | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.